Spun out of Cambridge University in mid 2004 to commercialize research findings in the areas of advanced nano-enabled materials, specifically in the area of carbon nanotube materials and their applications.
Randox Food Diagnostics is a division of Randox Laboratories who have 30 years experience in the diagnostic market and a devoted research and development team. Randox Food Diagnostics is a dedicated company responsible for the distribution of Randox drug residue kits, wine testing kits and analysers worldwide. Randox Food Diagnostics incorporate several market related products dedicated to the food, wine and beverage industries. Randox uses in house developed antibodies and conjugates for a wide range of their screening products including the patented Biochip Array Technology (multiplex screening platform).
ROAR is involved in the research, development and manufacturing of nanotechnology derived particles for commercial applications. In the short to medium term, the company will concentrate in supplying nanoparticles used for forensic, immigration and sports testing applications.
Swansea Engineering Aplication Solutions-Nanotechnology is an innovative technology solutions provider, working in conjuntion with organizations and offering technical support to their product line which includes proposal of process improvement and to promote their product at the most competitive price through the market.
Semefab Ltd. operates two Silicon wafer fabrication foundries in Glenrothes Scotland supporting a wide range of process technologies. Under the SemeMEMS Initiative, Semefab has been selected as the UK wafer fab node for Micro and Nanotechnology (MNT) and as such is an enabler for commercialization of industrial and academia research outcomes.
Sphere is commercializing picodroplet technology from Cambridge University that can perform thousands of simultaneous reactions on single cells and molecules contained within aqueous droplets, fractions of a millimeter in size. This platform enables diverse applications including: miniaturized profiling of drug candidates, generation of new biocatalysts and identification of novel algal strains.